Hospital and Drug Costs Are Squeezing U.S. Businesses as Health Inflation Spreads
Rising hospital charges and pharmaceutical prices are intensifying pressure on American employers, adding to a broader health-cost surge that is filtering through premiums, wages and corporate margins. The strain is increasingly visible in global markets as investors weigh the durability of earnings for companies exposed to U.S. healthcare inflation.
